Orchard Therapeutics
VerifiedWork at Orchard Therapeutics.
Orchard Therapeutics develops ex vivo autologous hematopoietic stem cell (HSC) gene therapies to treat rare genetic diseases such as metachromatic leukodystrophy (MLD), ADA-SCID, and mucopolysaccharidosis disorders. Their lead product, Libmeldy (OTL-200), targets early-onset MLD...
Open roles at Orchard Therapeutics
0 open rolesNo open roles are listed for this company right now.
Subscribe to Career Resources.
Get the latest career advice, industry insights, and job opportunities delivered straight to your inbox.
